Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Multidisciplinary Study Based on Clinical, Electrophysiological and Psycological Evaluations Combined with Advanced Neuroimaging in Gaucher Disease Patients

Fiorina Giona, MD, Carlo Di Bonaventura, MD, Patrizia Mancini, MD, Gianmarco Tessari, Turchetta Rosaria, MD, Emanuele Cerulli Irelli, MD, Stefano Ferracuti, Teresa Di Giallonardo, MD, Rocco Plateroti, MD, Francesca Atturo, MD, Luisa Cardarelli, MD, Giovanna Palumbo, MD, Marcella Nebbioso, MD, Tiziana Di Pippo, Francesca Caramia, MD

Blood (2019) 134 (Supplement_1): 2185.

https://doi.org/10.1182/blood-2019-128143

Published: 2019

Journal Articles

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predictive Biomarkers and Clinical Outcomes

Noa G. Holtzman, MD, Soren M. Bentzen, PhD DMSc, Vivek Kesari, MD, Ali Bukhari, MD, Firas El Chaer, MD, Elizabeth Hutnick, RN, Kathleen Ruehle, RN, Natalie Gahres, RN, Neil Porter, MD, Carl Shanholtz, MD, Mehmet Hakan Kocoglu, MD, Ashraf Z. Badros, Babak Saboury, MD MPH, Jean A. Yared, MD, Nancy M. Hardy, MD, Aaron P. Rapoport, Saurabh Dahiya, MD

Blood (2019) 134 (Supplement_1): 3239.

https://doi.org/10.1182/blood-2019-125400

Published: 2019

Journal Articles

Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 765.

https://doi.org/10.1182/blood-2019-125769

Published: 2019

Journal Articles

Resource Utilization Early after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

Gunjan L. Shah, MDMS, Jae H. Park, MD, Craig S. Sauter, MD, Elaine Duck, RN MS MA, Elizabeth Halton, NP-BC AOCNP, Maria Lia Palomba, MD, Connie Lee Batlevi, MD, Anas Younes, MD, Mark Blaine Geyer, MD, Eric L. Smith, MD PhD, Sham Mailankody, MBBS, Elena Mead, MD, Bianca Santomasso, MD PhD, Miguel-Angel Perales, MD, Paul Sabbatini, MD, Sergio Giralt, MD, Renier J. Brentjens, MD PhD, Peter Bach, MD

Blood (2018) 132 (Supplement 1): 616.

https://doi.org/10.1182/blood-2018-99-114093

Published: 2018

Journal Articles

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Elisa Sala, MD, Stephanie von Harsdorf, MD, Verena Wais, MD, Thanh Mai Anne Nguyen, MD, Raphael Beck, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD

Blood (2018) 132 (Supplement 1): 4601.

https://doi.org/10.1182/blood-2018-99-114977

Published: 2018

Journal Articles

Non-Invasive Multi-Modal Imaging to Evaluate Disease Severity in Sickle Cell Disease

Michelle Case, BS, Clara Huishi Zhang, PhD, Yvonne H Datta, MD, Stephen C Nelson, MD, Kalpna Gupta, PhD, Bin He, PhD

Blood (2016) 128 (22): 1315.

https://doi.org/10.1182/blood.V128.22.1315.1315

Published: 2016

Journal Articles

Recognition of Biomarkers of Brain Connectivity and Pain Using Multi-Modal Imaging in Patients with Sickle Cell Disease

Michelle Case, BS, Clara Zhang, PhD, John Mundahl, Yvonne Datta, MD, Stephen C Nelson, MD, Kalpna Gupta, PhD, Bin He, PhD

Blood (2015) 126 (23): 971.

https://doi.org/10.1182/blood.V126.23.971.971

Published: 2015

Journal Articles

Descriptive Study: sleep disorders breathing and Polysomnographic changes in Children and Adolescents with Sickle Cell Disease

Celia M. Campanaro, MD, Jose Carlos Pereira, Jr., MD, Jose Hugo Lins Pessoa, MD, Marcia Pradella Halimann, MD, Monica Favoreto, MD

Blood (2011) 118 (21): 4849.

https://doi.org/10.1182/blood.V118.21.4849.4849

Published: 2011

Journal Articles

Varialibility of Neurological Complications in the Treatment of Acute Lymphoblastic Leukemia:Experience of a Single Pediatric Institution

Rosanna Parasole, Fara Petruzziello, Nicoletta Marra, Luciano Marchese, Argia Mangione, Ernesto Cianciulli, Giuseppe Menna, Aldo Misuraca, Vincenzo Poggi

Blood (2008) 112 (11): 3939.

https://doi.org/10.1182/blood.V112.11.3939.3939

Published: 2008

Journal Articles

Risk of HHV6-Associated Post-Transplant Acute Limbic Encephalitis (PALE) after Umbilical Cord Blood Stem Cell Transplantation: A Cohort Analysis.

Francisco M. Marty, Vincent T. Ho, William W. Seeley, Corey S. Cutler, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin, Lindsey R. Baden

Blood (2006) 108 (11): 2929.

https://doi.org/10.1182/blood.V108.11.2929.2929

Published: 2006

Journal Articles

Targeted Molecular Therapy for Inherited Glycosylphosphatidylinositol Deficiency.

A.M. Almeida, MD, Y. Murakami, PhD, A. Baker, MD, Y. Maeda, PhD, Irene Roberts, PhD, Taroh Kinoshita, PhD, D.M. Layton, MD, A. Karadimitris, PhD

Blood (2006) 108 (11): 487.

https://doi.org/10.1182/blood.V108.11.487.487

Published: 2006

Journal Articles

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

Sonali Lakshminarayanan, MD, Paul Szabolcs, MD, Vinod K. Prasad, MD, MRCP, Suhag Parikh, MD, June Allison, RN, CPON, Susan J. Wood, MN, CPNP, Maria Escolar, MD, Joanne Kurtzberg, MD

Blood (2005) 106 (11): 2050.

https://doi.org/10.1182/blood.V106.11.2050.2050

Published: 2005

Journal Articles

Allogeneic BMT Followed by Substrate Deprivation Therapy with N-butyldeoxynojirimycin in a Child with Tay-Sachs Disease.

Hans J.F.M. Jacobs, Michel M.A.A.P. Willemsen, Ph.D., M.D., Jacqueline J.J. Groot-Loonen, Ph.D. M.D., Ron R.A. Wevers, Ph.D. M.D., Peter P.M. Hoogerbrugge, Ph.D. M.D.

Blood (2004) 104 (11): 5158.

https://doi.org/10.1182/blood.V104.11.5158.5158

Published: 2004

NARROW

Multidisciplinary Study Based on Clinical, Electrophysiological and Psycological Evaluations Combined with Advanced Neuroimaging in Gaucher Disease Patients

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predictive Biomarkers and Clinical Outcomes

Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Resource Utilization Early after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Non-Invasive Multi-Modal Imaging to Evaluate Disease Severity in Sickle Cell Disease

Recognition of Biomarkers of Brain Connectivity and Pain Using Multi-Modal Imaging in Patients with Sickle Cell Disease

Descriptive Study: sleep disorders breathing and Polysomnographic changes in Children and Adolescents with Sickle Cell Disease

Varialibility of Neurological Complications in the Treatment of Acute Lymphoblastic Leukemia:Experience of a Single Pediatric Institution

Risk of HHV6-Associated Post-Transplant Acute Limbic Encephalitis (PALE) after Umbilical Cord Blood Stem Cell Transplantation: A Cohort Analysis.

Targeted Molecular Therapy for Inherited Glycosylphosphatidylinositol Deficiency.

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

Allogeneic BMT Followed by Substrate Deprivation Therapy with N-butyldeoxynojirimycin in a Child with Tay-Sachs Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only